These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7519913)

  • 1. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
    Mandel SJ; Brent GA; Larsen PR
    Thyroid; 1994; 4(1):129-33. PubMed ID: 7519913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hyperthyroidism during pregnancy and lactation.
    Azizi F; Amouzegar A
    Eur J Endocrinol; 2011 Jun; 164(6):871-6. PubMed ID: 21389085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.
    Sarkar S; Bischoff LA
    Semin Reprod Med; 2016 Nov; 34(6):317-322. PubMed ID: 27741549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole.
    Mujtaba Q; Burrow GN
    Obstet Gynecol; 1975 Sep; 46(3):282-6. PubMed ID: 51489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero.
    Löllgen RM; Calza AM; Schwitzgebel VM; Pfister RE
    J Pediatr Endocrinol Metab; 2011; 24(3-4):215-8. PubMed ID: 21648296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of hypo- and hyperthyroidism in pregnancy].
    Lind P
    Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aplasia cutis as a teratogenic effect of methimazole].
    Díez-Delgado Rubio J; Belmonte Martín MJ; Calvo Bonachera MD; López Candel E
    An Esp Pediatr; 1999 Sep; 51(3):290-2. PubMed ID: 10575754
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of maternal hyperthyroidism and antithyroid drug therapy on congenital malformation of newborn infants].
    Lian XL; Bai Y; Xu YH; Dai WX; Guo ZS
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):511-5. PubMed ID: 16202286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero.
    Iwayama H; Hosono H; Yamamoto H; Oshiro M; Ueda N
    Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):680-4. PubMed ID: 17803201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of antithyroid drugs in pregnancy: update and therapy implications.
    Francis T; Francis N; Lazarus JH; Okosieme OE
    Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
    [No Abstract]   [Full Text] [Related]  

  • 14. Timing of Shift in Antithyroid Drug Therapy and Birth Defects.
    Andersen SL; Andersen S
    Thyroid; 2019 Jan; 29(1):155-156. PubMed ID: 30458113
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aplasia cutis congenita and antithyroid drugs during pregnancy: Case series and literature review].
    Sachs C; Tebacher-Alt M; Mark M; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2016; 143(6-7):423-35. PubMed ID: 27033749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic treatment of hyperthyroidism during pregnancy.
    Cassina M; Donà M; Di Gianantonio E; Clementi M
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):612-9. PubMed ID: 22511519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of antithyroid drugs should be reduced as much as possible in the first trimester].
    Andersen SL; Laurberg P
    Ugeskr Laeger; 2014 Sep; 176(39):. PubMed ID: 25294327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
    Azizi F; Khoshniat M; Bahrainian M; Hedayati M
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malformations following methimazole exposure in utero: an open issue.
    Ferraris S; Valenzise M; Lerone M; Divizia MT; Rosaia L; Blaid D; Nemelka O; Ferrero GB; Silengo M
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):989-92. PubMed ID: 14745920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thyroid dysfunction in pregnant women: clinical dilemmas].
    Vissenberg R; Goddijn M; Mol BW; van der Post JA; Fliers E; Bisschop PH
    Ned Tijdschr Geneeskd; 2012; 156(49):A5163. PubMed ID: 23218031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.